for the Period Ended 31 December 2025
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Current assets | |||
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 3 |
(
|
(
|
| Net current assets (liabilities): |
( |
( |
|
| Total assets less current liabilities: |
( |
( |
|
| Total net assets (liabilities): |
( |
( |
|
| Members' funds | |||
| Profit and loss account: |
( |
( |
|
| Total members' funds: |
( |
( |
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 December 2025
Basis of measurement and preparation
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Other creditors |
|
|
| Total |
|
|
The EAASM has had another successful year and has fulfilled its CIC obligations admirably and the Summer newsletter highlights this and can be seen at www.eaasm.eu. The EAASM continues to be actively involved with the EU Parliament and attends relevant meetings and contributes to healthcare debates in the Parliament bringing together MEPs, Commission and the Council. The EAASM continues to support the objectives and recommendations of the EU Healthcare Coalition to which it is a partner. Whilst the DOTPharmacy NABP top level domain name initiative largely resides with the ASOP EU Company, the EAASM continues to support this important activity. Working closely with an NABP colleague, we have made great efforts to raise awareness about this top level domain name amongst pharmacy bodies in the UK and beyond which provides a secure sefehaven for patients to obtain their prescription medicines online. The EAASM continues to support the objectives of the Capacity Enhancing Innovation working group (CEI). This is a collaborative initiative focused on showcasing innovative technologies and solutions as complementary approaches to tackling critical workforce shortages in European healthcare systems, By uniting a diverse range of healthcare stakeholders, the group promotes the adoption of practical, scalable innovations to support care delivery and inform forward-looking health policy. The EAASM has attended the meetings organised by the CEI and EU Health Coalition.
The above mentioned topics and activities have been communicated to its members and the EAASM Board (a board meeting was held on 12 August 2025) to review and agree the above activities and concomitant objectives. Communication regarding funding takes place with its members every year.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
17 July 2026
And signed on behalf of the board by:
Name: M P Isles
Status: Director